MAPT and early-onset autosomal dominant Alzheimer disease: In the research setting, Alzheimer’s disease can be defined using the National Institute on Aging and Alzheimer’s Association Research framework.58 This is a purely biological definition (i.e. not dependent on clinical symptoms), in which Alzheimer’s disease is identified through Amyloid-beta, Tau and Neurodegeneration (A, T and N).